Alvorlig ketoacidose hos en pasient med SGLT2-hemmer som diabetesmedisin

Diabetic ketoacidosis is rarely seen in patients with type 2 diabetes. Doctors and patients need to be aware that sodium-glucose cotransporter 2 (SGLT2) inhibitors increase the risk of diabetic ketoacidosis, also in patients with type 2 diabetes. Here we present the case of a woman in her forties hospitalised with severe diabetic ketoacidosis while undergoing treatment for a presumed type 2 diabetes.